๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Impact of a statewide childhood vaccine program in controlling hepatitis A virus infections in Alaska

โœ Scribed by Rosalyn J. Singleton; Sarah Hess; Lisa R. Bulkow; Louisa Castrodale; Ginger Provo; Brian J. McMahon

Book ID
116962873
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
234 KB
Volume
28
Category
Article
ISSN
0264-410X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A low rate of hepatitis B virus vaccine
A low rate of hepatitis B virus vaccine breakthrough infections in Mongolia
โœ Samreen Ijaz; Janchiv Khulan; Sara L. Bissett; R. Bridget Ferns; Pagbajabyn Nyma ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 142 KB ๐Ÿ‘ 1 views

A nation-wide hepatitis B virus (HBV) immunization program of all newborn babies was launched in Mongolia in 1991. However, the continuation of clinical icteric viral hepatitis infections in children led to the investigation to determine whether HBV breakthrough infections were occurring and if any

Seroprevalence of hepatitis B virus infe
Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: Five years after a mass hepatitis B vaccination program
โœ Yee-Jeng Tsen; Mei-Hwei Chang; Hong-Yuan Hsu; Chin-Yun Lee; Juei-Low Sung; Ding- ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 400 KB ๐Ÿ‘ 1 views

A nationwide hepatitis B vaccination program was launched in Taiwan in 1984. To study the impact of this ongoing program on hepatitis B virus (HBV) infection, a follow-up seroepidemiologic study was carried out in 1989 in a Taipei district where pre-vaccination seroepidemiology had been studied. HBV

Effect of postexposure vaccination in a
Effect of postexposure vaccination in a chimpanzee model of hepatitis A virus infection
โœ Dr. Betty H. Robertson; Eric H. D'Hondt; John Spelbring; Houwen Tian; K. Krawczy ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 335 KB ๐Ÿ‘ 1 views

## Abstract Passive transfer of antibodies to hepatitis A virus (HAV) in immune globulin (IG) effectively prevents hepatitis A when given after exposure, but does not provide lasting protection from infection. Hepatitis A vaccines have been shown to generate quickly levels of antibody equivalent to